Metformin can inhibit the NLRP3 inflammasome activation in ApoE-/- mice and inhibit diabetes-accelerated AS, at least in part by activating AMPK and regulating thioredoxin-1/thioredoxin interacting protein (70). Here, PRKAA1 is linked to diabetes mellitus.